Publications by authors named "S M Gaytan"

Liver fibrosis (LF) occurs when the liver tissue responds to injury or inflammation by producing excessive amounts of scar tissue, known as the extracellular matrix. This buildup stiffens the liver tissue, hinders blood flow, and ultimately impairs liver function. Various factors can trigger this process, including bloodborne pathogens, genetic predisposition, alcohol abuse, non-steroidal anti-inflammatory drugs, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease.

View Article and Find Full Text PDF
Article Synopsis
  • Cardiac fibrosis leads to heart dysfunction due to excess extracellular matrix in the heart, and this review explores the potential of nanotechnology in treating it.
  • It examines the key molecular players involved in cardiac fibrosis, like Matrix Metalloproteinases and Transforming Growth Factor-beta, which could serve as targets for new nano-therapies.
  • The review also addresses the advancements in nanoparticle engineering for drug delivery, the challenges faced in developing these therapies, and the potential for them to improve clinical outcomes for patients.
View Article and Find Full Text PDF

Doxorubicin is a highly effective chemotherapeutic agent widely used to treat a variety of cancers. However, the clinical application of doxorubicin is limited due to its adverse effects on several tissues. One of the most serious side effects of doxorubicin is cardiotoxicity, which results in life-threatening heart damage, leading to reduced cancer treatment success and survival rate.

View Article and Find Full Text PDF

Retinal degenerative diseases such as retinitis pigmentosa cause a progressive loss of photoreceptors that eventually prevents the affected person from perceiving visual sensations. The absence of a visual input produces a neural rewiring cascade that propagates along the visual system. This remodeling occurs first within the retina.

View Article and Find Full Text PDF